New inhaled therapy shows promise for rare lung complication
NCT ID NCT03814317
First seen Feb 06, 2026 · Last updated May 16, 2026 · Updated 15 times
Summary
This study tested an inhaled drug called treprostinil in 5 people with sarcoidosis who also had high blood pressure in the lungs and lung scarring. The goal was to see if the drug could improve blood flow and exercise ability. The treatment is meant to manage symptoms and slow disease progression, not cure the condition.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INTERSTITIAL LUNG DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University of Florida, Division of Pulmonary and Critical Care Medicine
Gainesville, Florida, 32610, United States
Conditions
Explore the condition pages connected to this study.